Why Were These Five Stocks Among The Top Gainers On Monday?

Finally, another top gainer on Monday is BioDelivery Sciences International, Inc. (NASDAQ:BDSI), whose stock has appreciated by over 11%. The rise of the stock comes after the company issued a statement saying that the US Food and Drug Administration (FDA) approved BELBUCA, a buccal film for use in patients with chronic pain. BELBUCA was developed in partnership with Endo Pharmaceuticals, a subsidiary of Endo International plc (NASDAQ:ENDP). However, despite today’s jump, BioDelivery Sciences International, Inc. (NASDAQ:BDSI)’s stock is 50% in the red year-to-date and investors have been cautious towards the stock so far, as only 23 elite investors reported long stakes equal to 18% of the company’s worth as of the end of June. Among them, Kevin Kotler‘s healthcare-focused Broadfin Capital reported a position containing 3.54 million shares, up by 58% on the quarter.

Disclosure: None